Markets.com Logo

ACUS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0$
  • Previous Close
    0$
  • 52 Week Change
    --
  • Day Range
    0.00$
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    9 283 M$
  • EPS
    0
  • Beta
    -0.158
  • Volume
    --

About

Amicus Therapeutics, Inc. (ACUS.US) is a biotechnology company focused on discovering, developing, and commercializing therapies for rare diseases. Their primary product is Galafold (migalastat), an oral precision medicine for Fabry disease, a rare genetic disorder. The company also has a pipeline of gene therapy and pharmacological chaperone programs targeting other rare diseases. Its stock is publicly traded on the NASDAQ under the ticker symbol ACUS.
XRP Price Prediction: Will XRP (Ripple) Outperform Bitcoin (BTC/USD) in 2026?

XRP Price Prediction: Will XRP (Ripple) Outperform Bitcoin (BTC/USD) in 2026?

Ghko B|--
Stock market analysis: Dow Jones (DJIA), S&P 500 and Nasdaq close higher today

Stock market analysis: Dow Jones (DJIA), S&P 500 and Nasdaq close higher today

Frances Wang|--
Oil prices spike over $110: Will oil prices keep going up amid Middle East crisis?

Oil prices spike over $110: Will oil prices keep going up amid Middle East crisis?

Ghko B|--
Stellar (XLM) price analysis: Will XLM/USD reach $1 in 2026?

Stellar (XLM) price analysis: Will XLM/USD reach $1 in 2026?

Ghko B|--
Crude oil prices continue to rise: How long could Middle East tensions keep international oil prices high?

Crude oil prices continue to rise: How long could Middle East tensions keep international oil prices high?

Ghko B|--
Crypto market outlook 2026: What crypto will explode next?

Crypto market outlook 2026: What crypto will explode next?

Ghko B|--
Oil market analysis: Middle East conflict fuels oil price surge, forecast turns volatile

Oil market analysis: Middle East conflict fuels oil price surge, forecast turns volatile

Ghko B|--

Factors

Industry Trends: The performance and outlook of the medical technology industry significantly influence ACUS.US's valuation.

Financial Performance: Revenue growth, profitability, and cash flow are key drivers of investor confidence.

Regulatory Environment: Changes in healthcare regulations and approvals impact ACUS.US's market access and growth.

Technological Innovation: Advancements and breakthroughs in medical technology can boost or hinder ACUS.US's competitiveness.

Market Sentiment: General investor optimism or pessimism affects the overall demand and supply of ACUS.US shares.

Competition: The presence and actions of competitors influence ACUS.US's market share and pricing power.

Economic Conditions: Macroeconomic factors such as interest rates and inflation impact investment decisions.

Company News: Announcements regarding product launches, partnerships, and acquisitions can significantly affect the stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B|--
CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B|--
CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Ghko B|--